03551nam a2200421zi 45000010014000000030008000140050017000220070015000390080041000540200028000950200025001230220014001480400031001620720016001930720015002090720015002242450092002392640054003313360021003853370023004063380032004293650110004613660044005714900036006155000047006515050489006985160013011875200892012005450721020926500034028136500033028476500033028807000028029137000031029417000027029728560062029998560068030619781849841092UK-WkNB20190830000000.0cu||||||||||||190830e201908uuxxk    |s|||||||0|0 eng|d  a9781849841092 :c$85.00  a1849841098 :c$85.00  a2312-5098  aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aAlpha-1-Antitrypsin Deficiency /cEdited by Pavel Strnad, Mark L. Brantly, Robert Bals. 1aSheffield :bEuropean Respiratory Society,c2019.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier  a02b85.00cUSDd00eThis price includes a tax elementhZ 85.00 0.00 85.00 0.00jGBkxxkmTEDITOR2onix-pt  b20190829cIP 20190830jGBkxxk2UK-WkNB0 aERS Monograph,x2312-5098 ;v85  aElectronic book text. Text (eye-readable).0 aPatient view-- Serpinopathies-- Genetics and epidemiology-- Laboratory diagnosis-- Mechanisms of lung disease-- Clinical approach to diagnosis and assessment-- Treatment of lung disease-- Mechanisms of liver disease-- Clinical approach to paediatric liver disease-- Clinical approach to liver disease in adults-- Rare manifestations-- Genetic counselling-- Registries: roles, objectives and registry data study outcomes-- Future directions: diagnostic approaches and therapy with AAT.  aDocument  aThis book covers basic biology, genetics, laboratory diagnostics and the major organ manifestations; describes the clinical presentation of AATD in adults and children; and features chapters on genetic counselling, patient views and future therapies. The content has been tailored to meet the needs of the physician and the general practitioners.bThis Monograph offers a comprehensive and up-to-date overview of AATD. It covers basic biology, genetics, laboratory diagnostics and the major organ manifestations; describes the clinical presentation of AATD in both adults and children; and features chapters on genetic counselling, patient views and future therapies. The content has been tailored to meet the needs of the physician, who takes care of lung and liver patients in daily practice, and the general practitioner, who is responsible for the medical guidance of these patients.0 aPavel Strnad is an Associate Professor and Senior Physician at the University Hospital Aachen, Aachen, Germany. He currently leads a European initiative for the study of AATD-associated liver disease. Mark L. Brantly is a Professor of Medicine and Chief of Molecular Genetics and Microbiology in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Florida College of Medicine in Gainesville (FL, USA), where his is also the Alpha-1 Foundation Research Professor. Robert Bals is the Director of the Saarland University's (Saarbrucken, Germany) Department of Pulmonology, where he focuses on teaching, research and patient care. Robert Bals established and manages the German AAT Registry. 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aStrnad, Pavel,eeditor.1 aBrantly, Mark L.,eeditor.1 aBals, Robert,eeditor.4 uhttp://ersbookshop.comx01zPublisher's corporate website4 uhttp://books.ersjournals.comx01zPublisher's corporate website